Latest / Concord News Today | 2 Min News | The Daily News Now!
FDA Approves First Alzheimer’s Drug in Years | Concord News
FDA just approved Lecanemab, a groundbreaking drug for early-stage Alzheimer’s that targets amyloid plaques and slows cognitive decline—offering hope but with caution, as side effects like brain swelling and bleeding are still a concern. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public reporting.Report issues to feedback@thednn.ai. View sources & latest updates:https://sources.thednn.ai/2c6c29a1cad86313
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.